Why Pharma must reinvent itself

12/1/2008 | Deloitte

The big pharmaceutical companies are in trouble. Patents are expiring, innovation is slowing and the next blockbuster is not in sight. "Only a transformation of the business model will position Large Pharma for future growth," say Deloitte analysts. This paper outlines the industry's limited opportunities and urges the companies to build on their commercial capabilities while the window of opportunity is still open.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Business

Job Title Company Location
Manager, Technical Staffing
U.S. Cellular
Chicago, IL
Human Resource Director
Salt Lake City, UT
Vice-President of Global Sales
Lindsay Corporation
Hartland, WI
Chief Operations Officer
Delta Community Supports
Blue Bell, PA
Administrative Management Specialist
Smithsonian Institute
Washington, DC